BEAM THERAPEUTICS INC (BEAM)
US07373V1052 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 287.85M | 435.89M | 232.80M | 560.00M | 162.20M | |||
| Marketable Securities | 806.71M | 753.98M | 845.40M | 405.70M | 137.50M | |||
| Receivables | N/A | N/A | 0.00 | 300.00M | N/A | |||
| Other Current Assets | 27.16M | 21.17M | 14.80M | 7.40M | 8.70M | |||
| Total Current Assets | 1.12B | 1.21B | 1.09B | 1.27B | 308.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 229.94M | 237.81M | 234.10M | 187.00M | 125.40M | |||
| Other Non-Current Assets | 8.14M | 10.87M | 14.70M | 14.50M | 18.00M | |||
| Total Non-Current Assets | 238.09M | 248.67M | 248.80M | 201.50M | 143.40M | |||
| TOTAL ASSETS | 1.36B | 1.46B | 1.34B | 1.47B | 451.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 484.00K | 1.90M | 2.30M | 2.10M | |||
| Accrued Expenses | 98.62M | 123.96M | 58.40M | 75.20M | 22.70M | |||
| Accounts Payable | 2.79M | 1.62M | 9.00M | 7.50M | 6.30M | |||
| Other Current Liabilities | 85.81M | 79.51M | 154.30M | 128.50M | 71.20M | |||
| Total Current Liabilities | 187.22M | 205.56M | 223.60M | 213.40M | 102.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 1.20M | 3.00M | 5.30M | |||
| Other Non-Current Liabilities | 259.09M | 272.82M | 383.50M | 431.30M | 98.50M | |||
| Total Non-Current Liabilities | 259.09M | 272.82M | 384.60M | 434.30M | 103.80M | |||
| TOTAL LIABILITIES | 446.31M | 478.38M | 608.20M | 647.70M | 206.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.29B | -1.19B | -1.06B | -768.30M | -397.60M | |||
| Additional Paid In Capital | 2.20B | 2.17B | 1.79B | 1.59B | 642.60M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 823.00K | 816.00K | 700.00K | 700.00K | 600.00K | |||
| Other Shareholders' Equity | -921.00K | 604.00K | -2.40M | -100.00K | 0.00 | |||
| Shares Outstanding | 82.28M | 81.63M | 71.30M | 68.40M | 57.30M | |||
| Tangible Book Value per Share | 11.10 | 12.02 | 10.29 | 12.09 | 4.29 | |||
| Total Shareholders' Equity | 913.49M | 981.33M | 733.50M | 826.70M | 245.60M | |||
| TOTAL LIABILITIES AND EQUITY | 1.36B | 1.46B | 1.34B | 1.47B | 451.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.00 | 0.00 | 0.02 | |||
| Current Ratio | 5.99 | 5.89 | 4.89 | 5.97 | 3.01 | |||
| Return On Assets (ROA) | -9.91% | -9.08% | -21.55% | -25.14% | -43.36% | |||
| Return On Equity (ROE) | -14.75% | -13.50% | -39.41% | -44.83% | -79.75% | |||
All data in USD